The types and driving genetic aberrations of these malignancies are different than those affecting the adult population, so a specifically designed, targeted but comprehensive panel is needed to advance clinical research and future precision oncology therapeutic solutions.
The Ion TorrentTM Oncomine Childhood Cancer Research Assay is a next-generation sequencing (NGS) assay designed for comprehensive genomic profiling of pediatric and rare cancer types including:
Compiled by leading researchers and pediatric oncologists, the Oncomine Childhood Cancer Research Assay provides coverage of 203 unique genes, including thousands of fusion drivers which more commonly occur in childhood sarcomas and leukemias.
The end-to-end workflow enables the analysis of a variety of sample types including blood and bone marrow, fresh/frozen tissue, and FFPE tissue in 2–3 days from sample to result. Up to 8 samples can be multiplexed on a single Ion 540 Chip, allowing for flexibility in batch size.
The Ion Torrent Genestudio platform is an advanced next-generation sequencing system that leverages semiconductor technology to enable fast, accurate, and cost-effective genomic analysis, making it suitable for a wide range of applications including targeted sequencing, gene expression profiling, and metagenomics.
Learn more about the fully integrated workflow based on the
Ion GeneStudio S5 System.
For Research Use Only. Not for use in diagnostic procedures.
We've detected your location to be Japan.
Sorry, you cannot access this website. The content on www.oncomine.com is only intended for healthcare professionals. Formore information on our research solutions, please visit ThermoFisher.com
このウェブサイトは、日本国内の医療関係者の方への情報提供を目的としており、一般の方に対する情報提供を目的としたものではないことをご了承ください。研究用製品の情報はThermoFisher.comよりご覧ください。